Viatris Trims FY22 Revenue Outlook, Declares Dividend - Update

RTTNews | 1023 dagar sedan
Stocktwits
Viatris Trims FY22 Revenue Outlook, Declares Dividend - Update

(RTTNews) - While reporting financial results for the second quarter on Monday, healthcare company Viatris Inc. (VTRS) trimmed its total revenue guidance for the full-year 2022 to reflect the incremental impact of foreign exchange.

For fiscal 2022, the company no projects total revenue between $16.2 billion and $15.7 billion, down from the prior forecast range of $17.0 billion to $17.5 billion. On average, ten analysts polled by Thomson Reuters expect the company to report revenues of $17.04 billion for the year.

The company also said its Board of Directors declared a 9 percent higher quarterly dividend of $0.12 for each issued and outstanding share of the company's common stock, payable on September 16, 2022, to shareholders of record at the close of business on August 24, 2022.

Taggar: VTRS
Stocktwits
read more
Viatris Announces US Commercial Launch Of RYZUMVl 0.75%

Viatris Announces US Commercial Launch Of RYZUMVl 0.75%

Healthcare company Viatris Inc. (VTRS) announced Monday the U.S. commercial launch of RYZUMVI (phentolamine ophthalmic solution) 0.75% for the treatment of pharmacologically-induced mydriasis produced by adrenergic agonists (e.g., phenylephrine) or parasympatholytic (e.g., tropicamide) agents in the U.S.
RTTNews | 421 dagar sedan
Viatris Guides FY24 In Line With Estimates - Update

Viatris Guides FY24 In Line With Estimates - Update

While reporting financial results for the fourth quarter on Wednesday, healthcare company Viatris Inc. (VTRS) initiated its adjusted earnings and revenue guidance for the full-year 2024.
RTTNews | 454 dagar sedan
Viatris Reaffirms FY22 Revenue Outlook, Declares Dividend - Update

Viatris Reaffirms FY22 Revenue Outlook, Declares Dividend - Update

While reporting financial results for the third quarter on Monday, healthcare company Viatris Inc. (VTRS) reaffirmed its total revenue guidance for the full-year 2022 to solid operating momentum despite foreign exchange headwinds and absorbing inflation impact to date.
RTTNews | 932 dagar sedan
U.S. District Court Rules In Favor Of Merck In Patent Infringement Suit Against Viatris

U.S. District Court Rules In Favor Of Merck In Patent Infringement Suit Against Viatris

Merck (MRK), known as MSD outside of the United States and Canada, announced Thursday that the U.S. District Court for the Northern District of West Virginia ruled in favor of the company in a patent infringement suit against Viatris, Inc. (VTRS) related to sitagliptin, an active ingredient in JANUVIA, JANUMET and JANUMET XR.
RTTNews | 978 dagar sedan
Singapore Bourse May Reclaim 3,900-Point Level

Singapore Bourse May Reclaim 3,900-Point Level

The Singapore stock market has alternated between positive and negative finishes through the last four trading days since the end of the two-day winning streak in which it had risen just 6 points or 0.15 percent. The Straits Times Index now sits just shy of the 3,900-point plateau and it's expected to open higher again on Wednesday.
RTTNews | 13 minuter sedan
Verktyg
Ekonomisk kalender
Market Hours
Interest Rates
Holidays Calendar
Forex Marknad
Forex Volatilitet
Forex Korrelation
Forex Nyheter
forex analysis
COT Data
Likviditet
Forex Kalkylatorer
Forex värmekarta
Indicators Heatmap
Gemenskapen
Gemenskapen
Systems
De mest populära systemen
Strategier
Tävlingar
Forex Diagram
Forex Sentiment
Indikator för utsikter
Recensioner
Mäklare
Prop Trading Firms
VPS-tjänster
Signalleverantörer
EA-programmeringstjänster
Affiliate Programs
PAMM mäklartjänster
Tjänster för rabattprogram
Trading Plattformar
Expertrådgivare
krypto Börser
Trading Courses
Mäklare
Forex Sprider sig
Forex Citat från mäklare
Forex mäklare Swaps
Forex Volym för mäklare
Forex Kampanjer för mäklare Press Release
Plattform
Widgetar
Funktioner
API
RSS
Stock Portfolio
Affiliate Software
Avancerade diagram
Stöd
FAQ
Hjälp
Kontakta oss
Rapportera en bugg!
Om
Blogg
© 2025 Myfxbook Ltd. Alla rättigheter reserverade
HIGH RISK WARNING: Valutahandel innebär en hög risknivå som kanske inte är lämplig för alla investerare. Hävstångseffekten skapar ytterligare risker och förlustexponering. Innan du bestämmer dig för att handla med utländsk valuta bör du noga överväga dina investeringsmål, din erfarenhetsnivå och din risktolerans. Du kan förlora en del av eller hela din ursprungliga investering. Investera inte pengar som du inte har råd att förlora. Utbilda dig om de risker som är förknippade med valutahandel och sök råd från en oberoende finansiell eller skatterådgivare om du har några frågor. Alla uppgifter och all information tillhandahålls endast i informationssyfte och är inte avsedda för handelsändamål eller rådgivning. Tidigare resultat är inte en indikation på framtida resultat.